As of 2026-04-08, the EV/EBITDA ratio of Novocure Ltd (NVCR) is -9.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novocure's latest enterprise value is 1,312.00 mil USD. Novocure's TTM EBITDA according to its financial statements is -139.23 mil USD. Dividing these 2 quantities gives us the above Novocure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 18.7x | 11.8x |
| Forward P/E multiples | 14.0x - 22.8x | 17.8x |
| Fair Price | (18.13) - (23.89) | (19.15) |
| Upside | -271.9% - -326.4% | -281.5% |
| Date | EV/EBITDA |
| 2026-04-06 | -9.42 |
| 2026-04-02 | -9.42 |
| 2026-04-01 | -9.66 |
| 2026-03-31 | -9.71 |
| 2026-03-30 | -9.27 |
| 2026-03-27 | -9.77 |
| 2026-03-26 | -10.41 |
| 2026-03-25 | -10.29 |
| 2026-03-24 | -10.09 |
| 2026-03-23 | -10.46 |
| 2026-03-20 | -10.45 |
| 2026-03-19 | -10.73 |
| 2026-03-18 | -10.66 |
| 2026-03-17 | -10.89 |
| 2026-03-16 | -10.92 |
| 2026-03-13 | -10.66 |
| 2026-03-12 | -10.62 |
| 2026-03-11 | -11.12 |
| 2026-03-10 | -11.22 |
| 2026-03-09 | -11.35 |
| 2026-03-06 | -11.46 |
| 2026-03-05 | -12.43 |
| 2026-03-04 | -11.77 |
| 2026-03-03 | -11.67 |
| 2026-03-02 | -11.85 |
| 2026-02-27 | -11.97 |
| 2026-02-26 | -12.04 |
| 2026-02-25 | -13.05 |
| 2026-02-24 | -10.40 |
| 2026-02-23 | -9.77 |
| 2026-02-20 | -10.09 |
| 2026-02-19 | -10.11 |
| 2026-02-18 | -10.12 |
| 2026-02-17 | -9.90 |
| 2026-02-13 | -9.78 |
| 2026-02-12 | -11.04 |
| 2026-02-11 | -9.38 |
| 2026-02-10 | -9.36 |
| 2026-02-09 | -9.00 |
| 2026-02-06 | -9.09 |
| 2026-02-05 | -9.05 |
| 2026-02-04 | -10.25 |
| 2026-02-03 | -10.48 |
| 2026-02-02 | -10.76 |
| 2026-01-30 | -10.94 |
| 2026-01-29 | -10.92 |
| 2026-01-28 | -11.08 |
| 2026-01-27 | -11.47 |
| 2026-01-26 | -11.64 |
| 2026-01-23 | -11.79 |